bioRxivPharmacology & Toxicology
Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology and Target Identification of Thio-wurtzine, a Potent Inhibitor of the Opioid Receptors and the Voltage-Dependent Calcium Channels
S. Aguero, S. Megy, R. Terreux, M. Fournier, D. Kulagina, S. Sysolyatin, A. Kalashnikov, S. Krylova, A. Vorozhtsov, V. Zhdanov
Abstract
The number of candidate molecules for new non-narcotic analgesics is extremely limited. Here we report the identification of thiowurtzine, a new potent analgesic molecule with promising application in chronic pain treatment. We describe the chemical synthesis of this unique compound derived from the hexaazaisowurtzitane (CL-20) explosive molecule. Then we use animal experiments to assess its analgesic activity in vivo upon chemical, thermal and mechanical exposures, compared to the effect of several reference drugs. Finally, we investigate the potential receptors of thiowurtzine in order to better understand its complex mechanism of action. We use docking, molecular modeling and molecular dynamics simulations to identify and characterize the potential targets of the drug and confirm the results of the animal experiments. Our findings finally indicate that thiowurtzine may have a complex mechanism of action, by targeting the mu, kappa, delta and ORL1 opioid receptors, and the voltage-gated calcium channels as well.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of SUR1 subtype KATP channels alters antinociception and locomotor activity after opioid administration
Gerald Sakamaki, Kayla Johnson, … Amanda H. Klein·Behavioural Brain ResearchPeer-reviewed·Jul 15, 2021
- KATP Channel Prodrugs Reduce Inflammatory and Neuropathic Hypersensitivity, Morphine Induced Hypersensitivity, and Precipitated Withdrawal in Mice
A. Doucette, K. Johnson, … A. H. Klein·bioRxiv·Nov 10, 2022
- Targeting the CaV - interaction yields a selective antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, … May Khanna·PainPeer-reviewed·Feb 5, 2019
- Selective Activation of TASK-3-containing K+ Channels Reveals Their Therapeutic Potentials in Analgesia
- Discovery of a Selective, State-Independent Inhibitor of NaV1.7 by Modification of Guanidinium Toxins
Hassan Pajouhesh, Jacob T. Beckley, … John V. Mulcahy·Scientific ReportsPeer-reviewed·Sep 9, 2020
- A novel small molecule PKC epsilon inhibitor reduces hyperalgesia induced by paclitaxel or opioid withdrawal
Adriana Gregory‐Flores, Ivan José Magayewski Bonet, … Michela Marinelli·bioRxiv·Jun 1, 2023